Quinolone antibiotics have been proposed as possible alternatives to vancomycin for methicillin-resistant Staphylococcus aureus infections. We investigated the activities of amifloxacin, ciprofloxacin, norfloxacin, and vancomycin by time-kill kinetic studies. Antibiotic concentrations of 0, 1.0, and 4.0 times the MIC were used against four strains of gentamicin-and methicillin-resistant S. aureus. Staphylococci were plated onto ciprofloxacin-containing agar at all time points, in repeat time-kill kinetic studies. Macrobroth dilution MICs and MBCs were determined. Ciprofloxacin levels were measured by bioassay. Replica plating was performed from the original susceptible inoculum (MIC, 0.125 ,g/ml) onto ciprofloxacin-supplemented agar. At 4.0 times the MIC, only with ciprofloxacin was there regrowth at 24 and 48 h. All four strains of staphylococci grew on agar supplemented with 1 ,g of ciprofloxacin per ml; three of four grew on agar supplemented with 2 ,g of ciprofloxacin per ml. MICs and MBCs for these resistant clones ranged from 8 to 32 ,g/ml. No degradation in activity or amount of ciprofloxacin could be detected in the bioassay. Replica-plated staphylococci grew on agar containing 1 ,g/ml but not higher concentrations of ciprofloxacin at 48 h. Amifloxacin and norfloxacin sustained bactericidal activity comparable to that of vancomycin. We conclude that heteroresistant subpopulations of gentamicin-and methicillin-resistant S. aureus can emerge under antibiotic selection pressure. Such resistant clones may then mutate in the presence of subinhibitory concentrations of antibiotic to higher levels of ciprofloxacin resistance.
Methicillin-resistant Staphylococcus aureus infections have increased significantly over the last 10 years (R. Wenzel, Letter, Ann. Intern. Med. 97:440-442, 1982 ). Methicillin-resistant S. aureus has become a major pathogen in patients who have nosocomial or community-acquired infections (14, 15, 18, 25) . Regardless of in vitro susceptibility results, no beta-lactam antibiotics can reliably be used to treat these infections. The quinolone antibiotics have been proposed as a possible alternative to parenteral vancomycin therapy on the basis of in vitro (1, 3, 21) and in vivo animal model (6) data. The present study was undertaken to compare the activities of several of the fluoroquinolone antibiotics and vancomycin against strains of gentamicin-and methicillin-resistant S. aureus, which has become a major pathogen at our institution (13) .
(This work was presented in part at the National Meeting of the American Federation for Clinical Research, Washington, D.C., 2 to 5 May 1986.) MATERIALS AND METHODS Strains. Ten strains of gentamicin-and methicillinresistant S. aureus were tested in this study. They were clinical isolates obtained from the Microbiology Laboratory at Edward Hines Jr. Veterans Administration Hospital, Hines, Ill. Before testing, the isolates were subcultured onto gentamicin-supplemented (10 ricidal activity of amifloxacin, ciprofloxacin, norfloxacin, and vancomycin by time-kill kinetic studies (19) . Each organism was added to cation-supplemented Mueller-Hinton broth with antibiotic concentrations of 0, 1.0, and 4.0 times the MIC of each antibiotic. Equal volumes (4 ml) of a 4-h mid-logarithmic-phase inoculum in Mueller-Hinton broth and sterile MuellerHinton broth were added to acid-washed borosilicate glass tubes. The inoculum density was between 0.5 x 106 and 1.0 x 106 CFU/ml of broth. All tubes were incubated aerobically at 35°C without shaking. Samples were removed from each tube at 0, 2, 4, 6, 8, 24, and 48 h postinoculation. Careful attention to vortexing at the time of sampling was strictly adhered to, in an attempt to ensure antibiotic exposure of any organisms contaminating glassware above the meniscus.
Serial dilutions of 100 to 106 were prepared from each sample in sterile saline, and 0.1 ml of each dilution was plated on Trypticase soy agar. All plates were incubated for 48 h at 35°C and then read for number of colonies. Each strain was studied by time-kill kinetics at least twice in duplicate samples for all four antibiotics.
Ciprofloxacin-treated S. aureus was tested an additional two times in duplicate, with the addition of plating onto ciprofloxacin-containing agar. Trypticase soy agar supplemented with 1 or 2 p,g of ciprofloxacin per ml was used in addition to antibiotic-free agar. Resistant isolates were retested by the macrobroth dilution method (11) for MIC and MBC determinations.
Replica plating. Detection of heterogeneous resistance to ciprofloxacin among the original inocula was performed by replica plating (12) . Inoculum plates were seeded with 0.1 ml of a 10-4 dilution of an overnight broth culture of gentamicinand methicillin-resistant S. aureus and after 24 h of incubation contained between 500 and 1,500 CFU. Each of the four strains ofgentamicin-and methicillin-resistant S. Ciprofloxacin levels. A bioassay procedure was used to determine the ciprofloxacin concentrations in the time-kill curve experiment. Samples (1 ml) were removed from both the control and ciprofloxacin-containing tubes at 8, 24 , and 48 h postincubation and were filter sterilized by using a 0.02-,um-pore membrane filter. Ciprofloxacin standards ranging in concentration from 1 to 0.03 ,ug/ml were prepared in phosphate-buffered saline and were filter sterilized. Bioassay plates were prepared by using antibiotic medium 11 (Difco Laboratories) and Klebsiella pneumoniae ATCC 10031 (protocol and organism kindly supplied by Barbara Painter, Miles Laboratories). A 32-ml volume of seeded agar was poured into sterile petri dishes (15 by 150 mm) and allowed to harden, and a series of 5-mm wells was cut in the agar. A 20-,ul volume each of ciprofloxacin standard or unknown was placed in duplicate wells. The plate was incubated at 35°C in a humidified atmosphere for 18 h, and zone diameters were measured. A standard curve was constructed by plotting log1o concentration versus zone size, and unknown concentrations were determined by using linear regression. RESULTS The MICs and MBCs of the fluoroquinolones and vancomycin are shown in Table 1 . Ciprofloxacin showed the greatest activity against the gentamicin-and methicillinresistant S. aureus strains with an MIC of 0.125 jig/ml for 90% of the strains as compared with MICs of 1.0 and 4.0 ,ug/ml for 90% of the strains for amifloxacin and norfloxacin, respectively. The MIC of vancomycin for 90% of the strains was 0.5 jLg/ml. Table 2 shows the MICs and MBCs for the four gentamicin-and methicillin-resistant S. aureus strains used in the time-kill kinetic studies. Figure 1 shows the time-kill kinetics of amifloxacin, ciprofloxacin, norfloxacin, and vancomycin. Bactericidal activity was judged to be present if there was a 99% reduction in survival from the original inoculum. At 1.0 times the MIC, amifloxacin and norfioxacin achieved a bactericidal effect at 8 h postinoculation; however, at 24 h regrowth of the organisms occurred. Ciprofloxacin and vancomycin were not bactericidal at the MIC. As expected, the concentration at 4.0 times the MIC showed the greatest bactericidal activitiy against the gentamicin-and methicillinresistant S. aureus strains. At 8 h, all the fluoroquinolones killed greater than 99% of the inoculum. However, at 24 h, there was regrowth only with ciprofloxacin. Data in Fig. 1 represent the mean organism titer (loglo) for all four strains of gentamicin-and methicdillin-resistant S. aureus tested. Each strain was studied by time-kill kinetics at least twice in duplicate samples.
Data presented in Table 3 demonstrate the emergence of resistance to ciprofloxacin at 24 and 48 h during the time-kill kinetic studies. Growth on agar supplemented with 1 j.g/ml occurred with all four strains by 48 h. Three of four strains also grew on agar supplemented with 2 ,ug of ciprofloxacin per ml. MICs and MBCs for each of the resistant strains as determined by the macrobroth dilution method are presented in Table 4 . Susceptibility values for the control strain S. aureus ATCC 29213 are included for purposes of comparison (Table 4) .
Ciprofloxacin levels were determined to be 0.5 ,ug/ml at each of the time intervals measured. Consequently, resistance occurred in the presence of the biologically active compound. No degradation in activity or amount of ciprofloxacin could be detected in the bioassay.
Replica plates onto ciprofloxacin-supplemented agar yielded no growth at 24 h. However, growth did occur by 48 h on agar supplemented with ciprofloxacin at concentrations of 0.5 and 1 p,g/ml. Approximately 100 CFU of each strain were isolated from replica plating onto agar containing either 0.5 or 1 ,ug of ciprofloxacin per ml.
DISCUSSION
The fluoroquinolones have emerged as a potentially important group of antimicrobial agents. They have been shown to be active against a wide variety of bacterial species in vitro (3, 5, 9, 21) . These antibiotics appear to act by antagonizing the A subunit of DNA gyrase, thereby blocking DNA replication (26) . Previous studies have shown that the fluoroquinolones have in vitro activity against S. aureus, including methicillin- resistant strains (1, 3, 4, 20, 21) . Gilbert et al. (6) have demonstrated equal efficacy' between enoxacin and vancomycin for the treatment of experimental methicillin-resistant S. aureus endocarditis.
Of the three fluoroquinolones we tested, ciprofloxacin had the greatest activity in vitro as compared with' amifloxacin and norfloxacin. The MIC of ciprofloxacin for 90%o of the strains was 0.125 ,ug/ml as compared with 1.0 ,uwg/ml for amifloxacin and 4.0 ,ug/ml for norfloxacin. These values are within the range of previously published MICs as determined by Simberkoff and Rahal (20) and by Del Bene and co-workers (4). The four isolates that were randomly chosen for the time-kill kinetic studies were very susceptible to ciprofloxacin. The mean MIC was 0.125 jig/ml, a value that is within the range of reported MICs for inethicillin-resistant S. aureus in several studies including those by Aldridge and co-workers (1) and Smith (21) . Thus, we feel confident that the clinical isolates utilized within this study were comparable to methicillin-resistant S. aureus from other laboratories. The total lack' of growth on replica plates supplemented with greater than 1 ,ug of ciprofloxacin per ml suggests that higher levels of resistance as measured in our resistant population may be due to induced or spontaneous mutation, whereas growth on ciprofloxacin agar at that concentration, from a susceptible inoculum, indicates the presence of a heteroresistant population of microorganisms within the original inoculum. As resistance occurred relatively quickly, we believe ciprofloxacin induced a one-step mutation similar to that seen with rifampin. Thus, the mechanism of resistance appears to be (i) selection of a heteroresistant population and (ii) induction of resistance to suprapharmacologic levels of antibiotic in the presence of subinhibitory concentrations of antibiotic.
One additional unexpected finding in our study was regrowth of gentamicin-and methicillin-resistant S. aureus in the presence of vancomycin at 4.0 times the MIC. Unlike Aldridge et al. (1) , our isolates appeared to develop resistance by 48 h. While we were not able to demonstrate tolerance (17) , evidence for vancomycin tolerance has been reported (22) .
It is important to note that the achievable concentrations of ciprofloxacin in serum are at least 10 times greater than the MICs for the original susceptible gentamicin-and methicillin-resistant S. aureus isolates, whereas the achievable serum concentration of norfloxacin is less than one-half the MIC for these same isolates (8, 23) . Comparable clinical pharmacology data for amifloxacin are currently unavailable. However, in vitro pharmacokinetic data for rats (10) suggest that amifloxacin may exceed the MIC for gentamicin-and methicillin-resistant S. aureus by severalfold.
Based on our time-kill kinetic studies, dosage frequency will be more important in sustaining bactericidal activity of ciprofloxacin as compared with norfloxacin or amifloxacin.
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